Buying KLOW in the USA: Four Peptides in Fixed Proportion

KLOW is not a molecule. It is four separate research peptides supplied together in one vial, which means any evaluation of it has to be built component by component. No meaningful literature treats the mixture as a mixture, so whatever assessment exists has to be assembled out of work done on the individual compounds.

Four families, four mechanisms, one vial

The combination is BPC-157, TB-500 (a thymosin β4 fragment), GHK-Cu and KPV. These come from four unrelated peptide families and act through unrelated mechanisms. Worth saying outright: this is a co-formulation, not a purpose-designed multi-target molecule of the sort that appears in incretin research.

What follows takes each component in turn, pairing what the indexed literature covers with the chemical identity that a certificate has to establish. Every component page below links to its own PubMed search, and none of these compounds is a variation on the others; they belong to distinct chemical classes and behave differently under analysis.

BPC-157

A synthetic 15-amino-acid sequence taken from a fragment of the human gastric juice protein BPC. The published record is overwhelmingly rodent work, much of it produced by a small number of research groups, and the mechanisms reported in those models center on nitric oxide signaling and on growth-factor receptor pathways. Indexed literature is reachable through PubMed.

Chemically it is a pentadecapeptide, GEPPPGKPADDAGLV, C62H98N16O22, roughly 1,419.5 g/mol, CAS 137525-51-0. The three consecutive prolines sitting mid-chain broaden its reverse-phase HPLC peak, because the bond in front of each proline flips between cis and trans conformations slowly relative to the timescale of the run. A broad or shouldered peak for this compound reflects the molecule itself and is not evidence of a second substance.

TB-500

TB-500 is emphatically not thymosin β4. It is a short acetylated fragment matching the thymosin beta-4 17–23 region: seven residues, C38H68N10O14, about 889 g/mol, CAS 885340-08-9. Full-length thymosin beta-4 runs 43 residues at roughly 4,963 g/mol, a 43-residue G-actin sequestering protein whose actin-binding motif is the portion most examined in cell-migration assays. Mass on the certificate is what tells the two apart. Background: the thymosin β4 literature, and our comparison of thymosin beta-4 with the TB-500 fragment.

GHK-Cu

Here the substance is a metal complex rather than a plain peptide: the tripeptide glycyl-L-histidyl-L-lysine coordinated to copper(II), C14H23CuN6O4, about 402.92 g/mol, CAS 89030-95-5. The copper is not an incidental passenger, since the activity studied in fibroblast culture attaches to the complex and not to the free tripeptide. That free tripeptide is a separate substance entirely, carrying registry number 49557-75-7 and a mass around 62 Da lower. See PubMed and our article on GHK-Cu and copper coordination.

KPV

Lys-Pro-Val, a tripeptide, C16H30N4O4, 342.43 g/mol, CAS 67727-97-3 — the C-terminal tripeptide of α-melanocyte-stimulating hormone. It has been looked at in cell and rodent models of intestinal inflammation, typically as a melanocortin-pathway fragment retaining some activity short of full receptor agonism. It appears in KLOW only. One search caution: querying “KPV” in a chemical database also turns up an unrelated small molecule, so the CAS number is what identifies the tripeptide. Literature: PubMed.

The per-component masses are the whole story

KLOW and GLOW are both supplied combinations rather than single molecules, and the breakdown is what matters:

• KLOW 80 mg — BPC-157 10 mg, TB-500 10 mg, GHK-Cu 50 mg, KPV 10 mg
• GLOW 70 mg — BPC-157 10 mg, TB-500 10 mg, GHK-Cu 50 mg

GLOW, in other words, is KLOW minus the KPV, and in both vials GHK-Cu accounts for over half the mass. Keep that in view when setting a blend beside a single-compound vial: 80 mg total reads as a lot next to a 10 mg vial, yet only 10 of those milligrams are BPC-157. The comparison that carries information is price per milligram of whichever component you actually need — see what cost per milligram hides.

The 80mg figure is a total across all four components, not 80mg of each. Anyone computing a concentration for one component needs the per-component breakdown, and gross peptide weight is in any case not the same as net peptide content once counter-ions and residual water enter the picture. Our note on net peptide content goes into that gap.

What a blend costs you analytically

Four peptides in a single vial create two problems that a single-compound vial does not have. Analytically, a blend has no single purity figure: each component carries its own retention time on RP-HPLC and its own mass, so a certificate must resolve all four instead of reporting one aggregate peak. Experimentally, an effect observed in a model system cannot be assigned to any one component unless the components are also run separately as controls.

Which is why experiments designed at component level generally start from individual peptides. BPC-157 and TB-500 and copper peptides are stocked on their own, with blends reserved for work in which the combination itself is the variable under study.

Four specific difficulties follow from combining them:

• Co-elution. Similar hydrophobicity means overlapping peaks on a reverse-phase column. KLOW’s two tripeptide-scale species and its two larger peptides sit far enough apart to resolve, but the trace is inevitably busier than a single compound’s, and interpreting it requires the method conditions.
• Ratio is its own measurement. Showing that each component is pure is a different exercise from showing the vial holds the stated proportions. The latter is quantitative, and a purity percentage does not report it.
• Uneven stability. Degradation rates differ across the components. Copper is redox active, making GHK-Cu the most condition-sensitive material present, while BPC-157 and KPV are comparatively robust. Practical shelf life follows the weakest component rather than the average.
• Nothing can be attributed. When a result looks off, a blend offers no route to pin it on one component. Where that matters, single vials combined at the bench serve better; the blend buys convenience at the cost of isolating a variable.

Further detail in reading an HPLC chromatogram and where peptide impurities come from.

Handling is dictated by the copper

Since GHK-Cu makes up more than half of either blend by mass, the vial’s handling requirements are essentially GHK-Cu’s. Copper complexes absorb visibly, which is why this material is blue instead of white; color is a crude indicator but a real one, and a cake that looks off-color or patchy is worth photographing when it arrives. Redox activity also makes the complex more responsive to light, oxygen and warmth than a plain tripeptide would be.

Keep it lyophilized, refrigerated and dark, and allow a sealed vial to warm to room temperature before opening so that atmospheric moisture condenses on glass rather than on powder. See how peptides degrade and what to check when a shipment arrives.

Four questions to put to a blend certificate

They are not the questions you would ask of a single compound:

• Has each component been identified by mass and not merely named? Four names next to one purity figure identifies nothing.
• Is composition given per component in milligrams rather than as a total?
• Is the detection wavelength stated? Purity at 214 nm and purity at 280 nm are not comparable, and because the components differ in aromatic content, the choice of wavelength shifts the apparent ratio.
• Can the batch be connected to the vial in front of you? Where ExoLabz publishes a certificate it carries photographs of the batch, and vials are matched by cap and crimp color rather than by a printed batch number.

Guidance on interpreting these documents is in how to read a certificate of analysis, and the most easily missed point of all is that in a blend, net content applies per component — see net peptide content.

Where to read further

Each component section above points to its indexed literature on PubMed. The third-party reports we have obtained are published on our certificates of analysis page; how to read a certificate of analysis explains how to interpret one.

ExoLabz supplies compounds for laboratory research use only. Nothing on this page is medical advice or a suggestion of human or veterinary use.

For KLOW next to the three-peptide GLOW blend, including cost per mg, read GLOW vs KLOW. All of our buying comparisons are on the peptide comparisons page.